$ORMP
ORAMED PHARMACEUTICALS INC. Stock $ormp

$ormp Overview Financials Valuation SEC Filings Company Website

2012 Q4 Form 10-Q Financial Statement

#000117891312003519 Filed on December 26, 2012

Income Statement

Concept	2012 Q4	2011 Q4
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$340.0K	$280.0K
YoY Change	21.43%	-12.5%
% of Gross Profit
Research & Development	$392.6K	$184.0K
YoY Change	113.37%	-35.77%
% of Gross Profit
Depreciation & Amortization	$2.271K	$6.042K
YoY Change	-62.41%	-18.91%
% of Gross Profit
Operating Expenses	$392.6K	$184.0K
YoY Change	113.37%	-35.77%
Operating Profit	-$731.8K	-$465.9K
YoY Change	57.07%	-22.56%
Interest Expense	-$230.0K	-$10.00K
YoY Change	2200.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$958.8K	-$478.5K
YoY Change	100.36%	-20.62%
Income Tax
% Of Pretax Income
Net Earnings	-$958.8K	-$478.5K
YoY Change	100.36%	-20.62%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$140.6K	-$82.19K
COMMON SHARES
Basic Shares Outstanding	86.51M
Diluted Shares Outstanding

Balance Sheet

Concept	2012 Q4	2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.600M	$3.680M
YoY Change	79.35%	234.55%
Cash & Equivalents	$5.531M	$1.496M
Short-Term Investments	$1.060M	$2.190M
Other Short-Term Assets	$40.00K	$40.00K
YoY Change	0.0%	0.0%
Inventory
Prepaid Expenses	$18.80K	$18.52K
Receivables	$75.95K	$86.00K
Other Receivables	$99.53K	$63.96K
Total Short-Term Assets	$6.808M	$3.865M
YoY Change	76.12%	195.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.497K	$11.33K
YoY Change	-77.97%	-71.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$10.00K	$10.00K
YoY Change	0.0%	0.0%
Other Assets	$10.00K	$10.00K
YoY Change	0.0%
Total Long-Term Assets	$16.98K	$37.09K
YoY Change	-54.23%	-25.81%
TOTAL ASSETS
Total Short-Term Assets	$6.808M	$3.865M
Total Long-Term Assets	$16.98K	$37.09K
Total Assets	$6.825M	$3.903M
YoY Change	74.88%	186.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$290.0K	$360.0K
YoY Change	-19.44%	5.88%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$334.6K	$424.4K
YoY Change	-21.16%	11.68%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$240.0K	$160.0K
YoY Change	50.0%	0.0%
Total Long-Term Liabilities	$240.4K	$160.8K
YoY Change	49.52%	0.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$334.6K	$424.4K
Total Long-Term Liabilities	$240.4K	$160.8K
Total Liabilities	$575.0K	$585.2K
YoY Change	-1.74%	8.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$18.85M	-$15.03M
YoY Change	25.45%
Common Stock	$24.86M	$18.35M
YoY Change	35.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.250M	$3.317M
YoY Change
Total Liabilities & Shareholders Equity	$6.825M	$3.903M
YoY Change	74.88%	186.95%

Cashflow Statement

Concept	2012 Q4	2011 Q4
OPERATING ACTIVITIES
Net Income	-$958.8K	-$478.5K
YoY Change	100.36%	-20.62%
Depreciation, Depletion And Amortization	$2.271K	$6.042K
YoY Change	-62.41%	-18.91%
Cash From Operating Activities	-$792.8K	-$484.1K
YoY Change	63.78%	-2.87%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$154.00	$1.061K
YoY Change	-85.49%
Cash From Investing Activities	$454.2K	$448.9K
YoY Change	1.18%	348.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.458M
YoY Change
NET CHANGE
Cash From Operating Activities	-$792.8K	-$484.1K
Cash From Investing Activities	$454.2K	$448.9K
Cash From Financing Activities	$1.458M
Net Change In Cash	$1.120M	-$35.13K
YoY Change	-3287.6%	-64.28%
FREE CASH FLOW
Cash From Operating Activities	-$792.8K	-$484.1K
Capital Expenditures
Free Cash Flow	-$792.8K	-$484.1K
YoY Change	63.78%	-2.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	dei	Amendment Flag AmendmentFlag	false
CY2012Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-31
CY2012Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2012Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2012Q4	dei	Document Period End Date DocumentPeriodEndDate	2012-11-30
CY2012Q4	dei	Document Type DocumentType	10-Q
CY2012Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001176309
CY2012Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	86505020
CY2012Q4	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2012Q4	dei	Entity Registrant Name EntityRegistrantName	ORAMED PHARMACEUTICALS INC.
CY2012Q4	ormp	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition Consultants AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognitionConsultants	28016	USD
	ormp	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition Consultants AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognitionConsultants	177782	USD
CY2008	ormp	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition Consultants AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognitionConsultants	203982	USD
CY2009	ormp	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition Consultants AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognitionConsultants	117174	USD
CY2010	ormp	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition Consultants AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognitionConsultants	116944	USD
CY2012	ormp	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition Consultants AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognitionConsultants	70292	USD
CY2011	ormp	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition Consultants AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognitionConsultants	26733	USD
	ormp	Adjustment To Additional Paid In Capital Imputed Interest AdjustmentToAdditionalPaidInCapitalImputedInterest	8437	USD
CY2008	ormp	Adjustment To Additional Paid In Capital Imputed Interest AdjustmentToAdditionalPaidInCapitalImputedInterest	3780	USD
CY2009	ormp	Adjustment To Additional Paid In Capital Imputed Interest AdjustmentToAdditionalPaidInCapitalImputedInterest	3780	USD
CY2010	ormp	Adjustment To Additional Paid In Capital Imputed Interest AdjustmentToAdditionalPaidInCapitalImputedInterest	3780	USD
CY2011	ormp	Adjustment To Additional Paid In Capital Imputed Interest AdjustmentToAdditionalPaidInCapitalImputedInterest	3782	USD
CY2012Q4	ormp	Discount On Convertible Note Related To Beneficial Conversion Feature DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature		USD
	ormp	Discount On Convertible Note Related To Beneficial Conversion Feature DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature	108000	USD
CY2011Q4	ormp	Discount On Convertible Note Related To Beneficial Conversion Feature DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature		USD
CY2012Q4	ormp	Exchange Of Warrants ExchangeOfWarrants	296982	USD
	ormp	Exchange Of Warrants ExchangeOfWarrants	296982	USD
CY2011Q4	ormp	Exchange Of Warrants ExchangeOfWarrants		USD
CY2012Q4	ormp	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Change In Fair Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetChangeInFairValue	118521	USD
CY2012Q4	ormp	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Change In Fair Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue	-44699	USD
CY2012Q4	ormp	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Exchange Of Warrants FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants	-620827	USD
CY2012Q4	ormp	Imputed Interest Expense ImputedInterestExpense		USD
	ormp	Imputed Interest Expense ImputedInterestExpense	23559	USD
CY2011Q4	ormp	Imputed Interest Expense ImputedInterestExpense		USD
CY2012Q4	ormp	Issuance Of Stock And Warrants For Future Services Or Claims IssuanceOfStockAndWarrantsForFutureServicesOrClaims		USD
	ormp	Issuance Of Stock And Warrants For Future Services Or Claims IssuanceOfStockAndWarrantsForFutureServicesOrClaims	24900	USD
CY2011Q4	ormp	Issuance Of Stock And Warrants For Future Services Or Claims IssuanceOfStockAndWarrantsForFutureServicesOrClaims	24900	USD
CY2012Q4	ormp	Proceeds From Receipts On Account Of Shares Issuances ProceedsFromReceiptsOnAccountOfSharesIssuances		USD
	ormp	Proceeds From Receipts On Account Of Shares Issuances ProceedsFromReceiptsOnAccountOfSharesIssuances	6061	USD
CY2011Q4	ormp	Proceeds From Receipts On Account Of Shares Issuances ProceedsFromReceiptsOnAccountOfSharesIssuances		USD
CY2008	ormp	Receipts On Account Of Shares And Warrants ReceiptsOnAccountOfSharesAndWarrants	6061	USD
CY2012Q4	ormp	Share Price Discount SharePriceDiscount	0.08
CY2012Q4	ormp	Shares And Warrants For Marketable Securities SharesAndWarrantsForMarketableSecurities	628630	USD
	ormp	Shares And Warrants For Marketable Securities SharesAndWarrantsForMarketableSecurities	628630	USD
CY2011Q4	ormp	Shares And Warrants For Marketable Securities SharesAndWarrantsForMarketableSecurities		USD
	ormp	Shares Cancelled Value SharesCancelledValue		USD
CY2012Q4	ormp	Shares Issued For Marketable Securities SharesIssuedForMarketableSecurities	628630	USD
CY2012Q4	ormp	Shares Issued For Marketable Securities Shares SharesIssuedForMarketableSecuritiesShares	917809
	ormp	Stock Issued During Period Value Offering Costs StockIssuedDuringPeriodValueOfferingCosts		USD
	ormp	Stock Issued During Period Value Services StockIssuedDuringPeriodValueServices	98750	USD
CY2008	ormp	Stock Issued During Period Value Services StockIssuedDuringPeriodValueServices	116110	USD
CY2009	ormp	Stock Issued During Period Value Services StockIssuedDuringPeriodValueServices	152928	USD
CY2010	ormp	Stock Issued During Period Value Services StockIssuedDuringPeriodValueServices	249850	USD
CY2012	ormp	Stock Issued During Period Value Services StockIssuedDuringPeriodValueServices	107860	USD
CY2011	ormp	Stock Issued During Period Value Services StockIssuedDuringPeriodValueServices	227569	USD
CY2012Q4	ormp	Warrant Liabilities Change In Fair Value WarrantLiabilitiesChangeInFairValue	-44699	USD
	ormp	Warrant Liabilities Change In Fair Value WarrantLiabilitiesChangeInFairValue	98005	USD
CY2011Q4	ormp	Warrant Liabilities Change In Fair Value WarrantLiabilitiesChangeInFairValue		USD
CY2012Q4	ormp	Warrants Exchanged WarrantsExchanged	917809	USD
	ormp	Warrants Exchanged WarrantsExchanged	917809	USD
CY2011Q4	ormp	Warrants Exchanged WarrantsExchanged		USD
CY2012Q4	ormp	Weighted Average Number Of Shares Outstanding Basic And Diluted Duration WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration	81912357
CY2011Q4	ormp	Weighted Average Number Of Shares Outstanding Basic And Diluted Duration WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration	70104583
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	287302	USD
CY2012Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	597173	USD
CY2012Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	47252	USD
CY2012Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	47252	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	75950	USD
CY2012Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	87691	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	235868	USD
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	24778025	USD
CY2012Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	21589715	USD
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	108000	USD
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	18991	USD
CY2012Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	190192	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1968547	USD
CY2008	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	459467	USD
CY2009	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	436025	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	690882	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	200866	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	502593	USD
CY2012Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	108000	USD
CY2011Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		USD
CY2012Q4	us-gaap	Assets Assets	6824867	USD
CY2012Q3	us-gaap	Assets Assets	5294851	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	6807889	USD
CY2012Q3	us-gaap	Assets Current AssetsCurrent	5276476	USD
CY2012Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	1064808	USD
CY2012Q3	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	200311	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5531075	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4430740	USD
CY2002Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1495615	USD
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1513365	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2012Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	86505020
CY2012Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80075725
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	86505020
CY2012Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80075725
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	86504	USD
CY2012Q3	us-gaap	Common Stock Value CommonStockValue	80075	USD
CY2012Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-722885	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18614662	USD
CY2011Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-474314	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16	USD
CY2012Q4	us-gaap	Contribution Of Property ContributionOfProperty		USD
	us-gaap	Contribution Of Property ContributionOfProperty	18991	USD
CY2011Q4	us-gaap	Contribution Of Property ContributionOfProperty		USD
CY2012Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent		USD
CY2012Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	454381	USD
CY2012Q4	us-gaap	Depreciation Depreciation	2271	USD
	us-gaap	Depreciation Depreciation	123115	USD
CY2011Q4	us-gaap	Depreciation Depreciation	6042	USD
CY2012Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		USD
CY2012Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	637182	USD
CY2012Q4	us-gaap	Due From Other Related Parties Current DueFromOtherRelatedPartiesCurrent	1719	USD
CY2012Q3	us-gaap	Due From Other Related Parties Current DueFromOtherRelatedPartiesCurrent	404	USD
CY2012Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.01
CY2011Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.01
CY2012Q4	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-19502	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-29570	USD
CY2011Q4	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	17381	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	628630	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	747151	USD
CY2012Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	28344	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		USD
CY2012Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	637182	USD
CY2012Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-18782	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-49819	USD
CY2011Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	21230	USD
CY2012Q4	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments		USD
	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	1033004	USD
CY2011Q4	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments		USD
CY2012Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	339213	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8500760	USD
CY2011Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	281901	USD
CY2012Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-958753	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18609754	USD
CY2011Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-478519	USD
CY2012Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2012Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-792826	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11073790	USD
CY2011Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-484070	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-958753	USD
	us-gaap	Net Income Loss NetIncomeLoss	-18850530	USD
CY2011Q4	us-gaap	Net Income Loss NetIncomeLoss	-478519	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4478917	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	240776	USD
CY2011Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2012Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-309870	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	287303	USD
CY2011Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-16920	USD
CY2012Q4	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities		USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	228272	USD
CY2011Q4	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities		USD
CY2012Q4	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	5215	USD
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	25401	USD
CY2011Q4	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	88	USD
CY2012Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	20962	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	181121	USD
CY2011Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	49727	USD
CY2012Q4	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash		USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	7509	USD
CY2011Q4	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash		USD
CY2012Q4	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities		USD
	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	16000	USD
CY2011Q4	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities		USD
CY2012Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	9316	USD
CY2012Q3	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	8867	USD
CY2012Q4	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1155956	USD
CY2011Q4	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6824867	USD
CY2012Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5294851	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	334554	USD
CY2012Q3	us-gaap	Liabilities Current LiabilitiesCurrent	644425	USD
CY2012Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	240446	USD
CY2012Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	872413	USD
CY2012Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	228272	USD
CY2012Q3	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	228272	USD
CY2012Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1064808	USD
CY2012Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	200311	USD
CY2012Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1458436	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16950375	USD
CY2011Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		USD
CY2012Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	454227	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-288476	USD
CY2011Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	448939	USD
CY2008	us-gaap	Net Income Loss NetIncomeLoss	-2769271	USD
CY2009	us-gaap	Net Income Loss NetIncomeLoss	-2760474	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	-2977376	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-3344478	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-1561245	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-731839	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18860956	USD
CY2011Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-465917	USD
CY2012Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	235868	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	235868	USD
CY2011Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4205	USD
CY2012Q4	us-gaap	Other Comprehensive Income Reclassification Adjustment For Write Down Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForWriteDownOfSecuritiesIncludedInNetIncomeNetOfTax	-117347	USD
	us-gaap	Other Comprehensive Income Reclassification Adjustment For Write Down Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForWriteDownOfSecuritiesIncludedInNetIncomeNetOfTax	-117347	USD
CY2011Q4	us-gaap	Other Comprehensive Income Reclassification Adjustment For Write Down Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForWriteDownOfSecuritiesIncludedInNetIncomeNetOfTax	-4205	USD
CY2012Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	118521	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	118521	USD
CY2011Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax		USD
CY2012Q3	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	637182	USD
CY2012Q4	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	299158	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	679538	USD
CY2011Q4	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	19556	USD
CY2012Q4	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	72244	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	279402	USD
CY2011Q4	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6954	USD
CY2012Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	99533	USD
CY2012Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	84642	USD
CY2012Q4	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet		USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	434876	USD
CY2011Q4	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet		USD
CY2012Q4	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities		USD
	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities	381666	USD
CY2011Q4	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities		USD
CY2012Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	154	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7049	USD
CY2011Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	1061	USD
CY2012Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	125612	USD
CY2011Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		USD
CY2012Q4	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		USD
CY2012Q3	us-gaap	Stockholders Equity StockholdersEquity	3778013	USD
CY2002Q2	us-gaap	Stockholders Equity StockholdersEquity	53700	USD
CY2011Q3	us-gaap	Stockholders Equity StockholdersEquity	3723916	USD
CY2010Q3	us-gaap	Stockholders Equity StockholdersEquity	830272	USD
CY2009Q3	us-gaap	Stockholders Equity StockholdersEquity	2746192	USD
CY2008Q3	us-gaap	Stockholders Equity StockholdersEquity	4593060	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	5903735	USD
CY2011Q4	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		USD
CY2012Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	12174	USD
CY2012Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	6959	USD
CY2012Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	18804	USD
CY2012Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2307	USD
CY2012Q4	us-gaap	Prepaid Pension Costs PrepaidPensionCosts	5165	USD
CY2012Q3	us-gaap	Prepaid Pension Costs PrepaidPensionCosts	4740	USD
CY2012Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	275000	USD
CY2011Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		USD
CY2012Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1458436	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	16603071	USD
CY2011Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		USD
CY2012Q4	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	120000	USD
CY2011Q4	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		USD
CY2012Q4	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	66243	USD
CY2011Q4	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		USD
CY2012Q4	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	454381	USD
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	5882381	USD
CY2011Q4	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments		USD
CY2012Q4	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments		USD
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	450000	USD
CY2011Q4	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	450000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2497	USD
CY2012Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4768	USD
CY2012Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	120000	USD
CY2011Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		USD
CY2012Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	392626	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9925320	USD
CY2011Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	184016	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	16000	USD
CY2012Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	16000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18850530	USD
CY2012Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17891777	USD
CY2012Q4	us-gaap	Share Based Compensation ShareBasedCompensation	218208	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5189495	USD
CY2011Q4	us-gaap	Share Based Compensation ShareBasedCompensation	51296	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	6249867	USD
CY2012Q4	us-gaap	Stock Issued1 StockIssued1		USD
	us-gaap	Stock Issued1 StockIssued1	77779	USD
CY2011Q4	us-gaap	Stock Issued1 StockIssued1		USD
CY2008	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	275000	USD
CY2012Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1430092	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2122981	USD
CY2008	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5784800	USD
CY2012	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2944464	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3694212	USD
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	434876	USD

Files In Submission

Name	View Source	Status
0001178913-12-003519-index-headers.html	Edgar Link	pending
0001178913-12-003519-index.html	Edgar Link	pending
0001178913-12-003519.txt	Edgar Link	pending
0001178913-12-003519-xbrl.zip	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
exhibit_32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
ormp-20121130.xml	Edgar Link	completed
ormp-20121130.xsd	Edgar Link	pending
ormp-20121130_cal.xml	Edgar Link	unprocessable
ormp-20121130_def.xml	Edgar Link	unprocessable
ormp-20121130_lab.xml	Edgar Link	unprocessable
ormp-20121130_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk1212411.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORMP
ORAMED PHARMACEUTICALS INC. Stock $ormp

2012 Q4 Form 10-Q Financial Statement

#000117891312003519 Filed on December 26, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORMP ORAMED PHARMACEUTICALS INC. Stock $ormp

2012 Q4 Form 10-Q Financial Statement

#000117891312003519 Filed on December 26, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORMP
ORAMED PHARMACEUTICALS INC. Stock $ormp